These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 1372283)

  • 1. Activation of human natural killer cells by the protein-bound polysaccharide PSK independently of interferon and interleukin 2.
    Kariya Y; Inoue N; Kihara T; Okamoto N; Sugie K; Mori T; Uchida A
    Immunol Lett; 1992 Feb; 31(3):241-5. PubMed ID: 1372283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lysis of fresh human tumor cells by autologous peripheral blood lymphocytes and tumor-infiltrating lymphocytes activated by PSK.
    Kariya Y; Okamoto N; Fujimoto T; Inoue N; Kihara T; Sugie K; Yagita M; Kanzaki H; Mori T; Uchida A
    Jpn J Cancer Res; 1991 Sep; 82(9):1044-50. PubMed ID: 1938599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation by the protein-bound polysaccharide PSK (krestin) of cytotoxic lymphocytes that act on fresh autologous tumor cells and T24 human urinary bladder transitional carcinoma cell line in patients with urinary bladder cancer.
    Mizutani Y; Yoshida O
    J Urol; 1991 May; 145(5):1082-7. PubMed ID: 2016797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein-bound polysaccharide (PSK) induces cytotoxic activity in the NKL human natural killer cell line.
    Pedrinaci S; Algarra I; Garrido F
    Int J Clin Lab Res; 1999; 29(4):135-40. PubMed ID: 10784373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of hepatic natural killer activity by liver metastasis of cancer and restoration of killer activity by oral administration of a Basidomycetes-derived polysaccharide, PSK.
    Suo J; Tanaka N; Hizuta A; Yunoki S; Orita K
    Acta Med Okayama; 1994 Oct; 48(5):237-42. PubMed ID: 7863794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cell functions of IL-2-activated tumor-infiltrating lymphocytes from renal cell carcinoma.
    Morita T; Salmeron MA; Hayakawa K; Swanson DA; von Eschenbach AC; Itoh K
    Reg Immunol; 1992; 4(4):225-35. PubMed ID: 1476875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TLR2 agonist PSK activates human NK cells and enhances the antitumor effect of HER2-targeted monoclonal antibody therapy.
    Lu H; Yang Y; Gad E; Inatsuka C; Wenner CA; Disis ML; Standish LJ
    Clin Cancer Res; 2011 Nov; 17(21):6742-53. PubMed ID: 21918170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production by human squamous cell carcinoma of a factor inducing activation and proliferation of immune cells.
    Hirabayashi H; Yasumura S; Lin WC; Amoscato A; Johnson JT; Herberman RB; Whiteside TL
    Arch Otolaryngol Head Neck Surg; 1995 Mar; 121(3):285-92. PubMed ID: 7873144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysis of fresh human tumor cells by autologous large granular lymphocytes and T-lymphocytes: two distinct killing activities induced by coculture with autologous tumor.
    Uchida A; Moore M
    J Natl Cancer Inst; 1984 Dec; 73(6):1285-92. PubMed ID: 6239944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of natural and recombinant IL 2 on regulation of IFN gamma production and natural killer activity: lack of involvement of the Tac antigen for these immunoregulatory effects.
    Ortaldo JR; Mason AT; Gerard JP; Henderson LE; Farrar W; Hopkins RF; Herberman RB; Rabin H
    J Immunol; 1984 Aug; 133(2):779-83. PubMed ID: 6203980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysis of fresh human tumour cells by autologous tumour-associated lymphocytes: two distinct types of autologous tumour killer cells induced by co-culture with autologous tumour.
    Uchida A; Moore M
    Cancer Immunol Immunother; 1985; 20(1):29-37. PubMed ID: 3877561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross regulation by IL-10 and IL-2/IL-12 of the helper T cells and the cytolytic activity of lymphocytes from malignant effusions of lung cancer patients.
    Chen YM; Yang WK; Ting CC; Tsai WY; Yang DM; Whang-Peng J; Perng RP
    Chest; 1997 Oct; 112(4):960-6. PubMed ID: 9377959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of CD3- lymphocyte function with an antibody against the IL-2 beta chain receptor: modulation of NK and LAK activity and production of IFN gamma.
    Ortaldo JR; Frey J; Takeshita T; Sugamura K
    Eur Cytokine Netw; 1990; 1(1):27-34. PubMed ID: 2151685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-draining lymph nodes of primary lung cancer patients: a potent source of tumor-specific killer cells and dendritic cells.
    Kimura H; Dobrenkov K; Iida T; Suzuki M; Ando S; Yamamoto N
    Anticancer Res; 2005; 25(1A):85-94. PubMed ID: 15816523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural killer (NK)-resistant human lung cancer cells are lysed by recombinant interleukin-2-activated NK cells.
    Robinson BW; Morstyn G
    Cell Immunol; 1987 May; 106(2):215-22. PubMed ID: 3494538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of human autotumor-reactive T-cell clones obtained from tumor-infiltrating lymphocytes in liver metastasis of gastric carcinoma.
    Shimizu Y; Weidmann E; Iwatsuki S; Herberman RB; Whiteside TL
    Cancer Res; 1991 Nov; 51(22):6153-62. PubMed ID: 1718596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural killer cell immunodeficiency in patients with chronic myelogenous leukemia. IV. Interleukin-1 deficiency, gamma-interferon deficiency and the restorative effects of short-term culture in the presence of interleukin-2 on natural killer cytotoxicity, natural killer-target binding and production of natural killer cytotoxic factor.
    Chang WC; Hsiao MH; Pattengale PK
    Nat Immun Cell Growth Regul; 1991; 10(2):57-70. PubMed ID: 1881400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxicity tests against cultured human lung cancer cells with autologous lymphocytes activated in vitro by mitomycin C-treated tumor monolayers in the presence of T-cell growth factor.
    Kimura H; Yamaguchi Y; Kadoyama C; Sato N; Fujisawa T
    Jpn J Clin Oncol; 1983 Mar; 13(1):3-13. PubMed ID: 6300483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of T-cell response in autologous mixed lymphocyte-tumor culture by large granular lymphocytes.
    Uchida A; Klein E
    J Natl Cancer Inst; 1986 Mar; 76(3):389-98. PubMed ID: 2419621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor.
    Carson WE; Giri JG; Lindemann MJ; Linett ML; Ahdieh M; Paxton R; Anderson D; Eisenmann J; Grabstein K; Caligiuri MA
    J Exp Med; 1994 Oct; 180(4):1395-403. PubMed ID: 7523571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.